These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19373022)

  • 1. Microbicide delivery: formulation technologies and strategies.
    Romano J; Malcolm RK; Garg S; Rohan LC; Kaptur PE
    Curr Opin HIV AIDS; 2008 Sep; 3(5):558-66. PubMed ID: 19373022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical development of microbicide drug products.
    Friend DR
    Pharm Dev Technol; 2010 Dec; 15(6):562-81. PubMed ID: 20017601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in microbicide vaginal rings.
    Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
    Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicides for HIV prevention: reality or hope?
    McGowan I
    Curr Opin Infect Dis; 2010 Feb; 23(1):26-31. PubMed ID: 19935418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal microbicides.
    McGowan I; Anton P
    Curr Opin HIV AIDS; 2008 Sep; 3(5):593-8. PubMed ID: 19373027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbicides: chemistry, structure, and strategy.
    Zydowsky TM
    Curr Opin HIV AIDS; 2008 Sep; 3(5):548-53. PubMed ID: 19373020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
    Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
    J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicides for the prevention of HIV infection in women: an overview of recent trials.
    Rosenberg ZF; Nel A; Heyward W; Mitchnick M
    Curr Opin HIV AIDS; 2006 Nov; 1(6):514-9. PubMed ID: 19372855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbicide research: current and future directions.
    Ramjee G
    Curr Opin HIV AIDS; 2010 Jul; 5(4):316-21. PubMed ID: 20543607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbicide acceptability research: current approaches and future directions.
    Mantell JE; Myer L; Carballo-Diéguez A; Stein Z; Ramjee G; Morar NS; Harrison PF
    Soc Sci Med; 2005 Jan; 60(2):319-30. PubMed ID: 15522488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future strategies in microbicide development.
    Rosenberg ZF; Devlin B
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):503-13. PubMed ID: 22406260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates.
    Promadej-Lanier N; Smith JM; Srinivasan P; McCoy CF; Butera S; Woolfson AD; Malcolm RK; Otten RA
    J Med Primatol; 2009 Aug; 38(4):263-71. PubMed ID: 19476564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
    Kieweg SL; Katz DF
    J Biomech Eng; 2006 Aug; 128(4):540-53. PubMed ID: 16813445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges.
    Nunes R; Sarmento B; das Neves J
    J Control Release; 2014 Nov; 194():278-94. PubMed ID: 25229988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicide dosage forms.
    Rohan LC; Devlin B; Yang H
    Curr Top Microbiol Immunol; 2014; 383():27-54. PubMed ID: 24220751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
    Patton DL; Cosgrove Sweeney YT; Paul KJ
    Sex Transm Dis; 2008 Oct; 35(10):889-97. PubMed ID: 18607310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical models and health economic aspects of microbicides.
    Wilson DP; Coplan PM
    Curr Opin HIV AIDS; 2008 Sep; 3(5):587-92. PubMed ID: 19373026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.